Acadian Asset Management
BCAB icon

Acadian Asset Management’s BioAtla BCAB Stock Holding History

Acadian Asset Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58K Sell
14,294
-10,384
-42% -$44K ﹤0.01% 1837
2026
Q1 		$198K Buy
24,678
+9,525
+63% +$111K ﹤0.01% 1591
2025
Q4 		$429K Sell
15,153
-3,456
-19% -$135K ﹤0.01% 1345
2025
Q3 		$638K Sell
18,609
-11,242
-38% -$260K ﹤0.01% 1160
2025
Q2 		$589K Sell
29,851
-3,951
-12% -$80.1K ﹤0.01% 1102
2025
Q1 		$585K Buy
33,802
+30,640
+969% +$655K ﹤0.01% 1054
2024
Q4 		$92K Buy
+3,162
New +$265K ﹤0.01% 1379
2024
Q3 		– Sell
-1,501
Closed -$102K – 2086
2024
Q2 		$102K Sell
1,501
-1,603
-52% -$191K ﹤0.01% 1534
2024
Q1 		$532K Buy
3,104
+1,135
+58% +$141K ﹤0.01% 988
2023
Q4 		$241K Buy
+1,969
New +$171K ﹤0.01% 1198
2023
Q2 		– Sell
-1,854
Closed -$247K – 1729
2023
Q1 		$247K Buy
1,854
+772
+71% +$139K ﹤0.01% 1214
2022
Q4 		$446K Sell
1,082
-907
-46% -$376K ﹤0.01% 1068
2022
Q3 		$765K Sell
1,989
-1,061
-35% -$347K ﹤0.01% 871
2022
Q2 		$435K Buy
+3,050
New +$485K ﹤0.01% 1018

Other funds holding BCAB

Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Acadian Asset Management's BCAB Position: Q2 2026 in Review

Acadian Asset Management reduced its BioAtla (BCAB) stake by 42% in Q2 2026, selling an estimated $44K and leaving 14,294 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #1837.

Acadian Asset Management first reported a position in BCAB in Q2 2022 and has held it in 14 quarters since. The position peaked at $765K in Q3 2022. 14 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Acadian Asset Management held 14,294 shares of BioAtla worth $58K as of Q2 2026.
  • Acadian Asset Management sold 10,384 BioAtla shares in Q2 2026, an estimated $44K.
  • BioAtla made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1837 holding.
  • Acadian Asset Management first reported a position in BioAtla in Q2 2022 and has held it in 14 quarters since.
  • Acadian Asset Management's BioAtla position peaked at $765K in Q3 2022.
  • 14 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.